인간 A549 폐암 세포에서 더덕 뿌리 추출물의 세포 증식 및 침습 억제 효과

키워드

참고문헌 (47)

1. Slatore C, "Staging of Lung Cancer", Am J Respir Crit Care Med, 205(9), pp.17~19 (2022)
2. Spira A, "Multidisciplinary management of lung cancer", N Engl J Med, 350(4), pp.379~392 (2004)
3. Mithoowani H, "Non-small-cell lung cancer in 2022 : a review for general practitioners in oncology", Curr Oncol, 29(3), pp.1828~1839 (2022)
4. Zhu T, "Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis", Front Oncol, 10, pp.585284~ (2020)
5. Korpanty G, "Update on anti-angiogenic therapy in non-small cell lung cancer : Are we making progress?", J Thorac Dis, 3(1), pp.19~29 (2011)
6. Islam KM, "Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer", BMC Cancer, 19(1), pp.835~ (2019)
7. Serrano-Gomez SJ, "Regulation of epithelial–mesenchymal transition through epigenetic and post-translational modifications", Mol Cancer, 15(1), pp.18~ (2016)
8. Gavert N, "Epithelial-mesenchymal transition and the invasive potential of tumors", Trends Mol Med, 14(5), pp.199~209 (2008)
9. Xu J, "TGF-β-induced epithelial to mesenchymal transition", Cell Res, 19(2), pp.156~172 (2009)
10. Takeda Y, "Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor(EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations", BMC Cancer, 20(1), pp.951~ (2020)
11. Zhu X, "EMT-mediated acquired EGFR-TKI resistance in NSCLC : mechanisms and strategies", Front Oncol, 9, pp.1044~ (2019)
12. Gonzalez DM, "Signaling mechanisms of the epithelial–mesenchymal transition", Sci Signal, 7(344), pp.re8~ (2014)
13. Willis BC, "TGF-β-induced EMT : mechanisms and implications for fbrotic lung disease", Am J Physiol Lung Cell Mol Physiol, 293(3), pp.L525~ (2007)
14. Lee KT, "Structure of a new echinocystic acid bisdesmoside isolated from Codonopsis lanceolata roots and the cytotoxic activity of prosapogenins", J Agric Food Chem, 50(15), pp.4190~4193 (2002)
15. Hossen MJ, "Codonopsis lanceolata : A Review of Its Therapeutic Potentials", Phytother Res, 30(3), pp.347~356 (2016)
16. Yoo HH, "Quality control of dried roots of Codonopsis lanceolata", Kor J Pharmacogn, 33(2), pp.85~87 (2002)
17. Han EG, "Effect of Codonopsis lanceolata water extract on the levels of lipid in rats fed high fat diet", J Korean Soc Food Sci Nutr, 27, pp.940~944 (1998)
18. Wang MC, "Polyacetylenes from Codonopsis lanceolata Root Induced Apoptosis of Human Lung Adenocarcinoma Cells and Improved Lung Dysbiosis", Biomed Res Int, 2022, pp.7713355~ (2022)
19. Byeon SE, "Inhibitory effect of saponin fraction from Codonopsis lanceolata on immune cell-mediated inflammatory responses", Arch Pharm Res, 32(6), pp.813~822 (2009)
20. Xu LP, "Triterpenoid saponins with anti-inflammatory activity from Codonopsis lanceolata", Planta Med, 74(11), pp.1412~1415 (2008)
21. Du YE, "Chemical constituents of the roots of Codonopsis lanceolata", Arch Pharm Res, 41(11), pp.1082~1091 (2018)
22. Lv P, "Pathogenesis and therapeutic strategy in platinum resistance lung cancer", Biochim Biophys Acta Rev Cancer, 1876(1), pp.188577~ (2021)
23. Chen JA, "Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors", J Thorac Dis, 12(5), pp.2859~2876 (2020)
24. Li Z, "Traditional Chinese medicine and lung cancer--From theory to practice", Biomed Pharmacother, 137, pp.111381~ (2021)
25. Ni M, "Investigation on the Efficiency of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Vinorelbine and Cisplatin Based on Multidimensional Bayesian Network Meta-Analysis", Front Pharmacol, 11, pp.631170~ (2021)
26. Chen RL, "Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice", Int Immunopharmacol, 94, pp.107357~ (2021)
27. Joh EH, "Pleckstrin homology domain of Akt kinase : a proof of principle for highly specific and effective non-enzymatic anti-cancer target", PLoS One, 7(11), pp.e50424~ (2012)
28. Du YE, "Chemical constituents of the roots of Codonopsis lanceolata", Arch Pharm Res, 41(11), pp.1082~1091 (2018)
29. Li W, "Anti-Tumor Effect of Steamed Codonopsis lanceolata in H22 Tumor-Bearing Mice and Its Possible Mechanism", Nutrients, 7(10), pp.8294~8307 (2015)
30. Jiang N, "Role of PI3K", AKT pathway in cancer : the framework of malignant behavior, 2020, pp.47(6), 4587~4629
31. Tan AC, "Targeting the PI3K", Akt, Thorac Cancer, pp.2020, 11(3)[DOI]
32. Ghomlaghi M, "Feedback, Crosstalk and Competition : Ingredients for Emergent Non-Linear Behaviour in the PI3K", mTOR Signalling Network, 2021, pp.22(13), 6944~
33. Conciatori F, "PTEN Function at the Interface between Cancer and Tumor Microenvironment : Implications for Response to Immunotherapy", Int J Mol Sci, 21(15), pp.5337~ (2020)
34. Kang BW, "Molecular target : pan-AKT in gastric cancer", ESMO Open, 5(5), pp.e000728~ (2020)
35. Ribatti D, "Epithelial-Mesenchymal Transition in Cancer : A Historical Overview", Transl Oncol, 13(6), pp.100773~ (2020)
36. Ahn JH, "Lancemaside A Isolated from the Root of Codonopsis lanceolata Inhibits Ovarian Cancer Cell Invasion via the Reactive Oxygen Species(ROS)-Mediated p38 Pathway", Am J Chin Med, 48(4), pp.1021~1034 (2020)
37. Liu Y, "Codonopsis lanceolata polysaccharide CLPS inhibits melanoma metastasis via regulating integrin signaling", Int J Biol Macromol, 103, pp.435~440 (2017)
38. So J, "Effects of Codonopsis lanceolata extracts on bFGF-induced angiogenesis in vitro", Korean J Biotechnol Bioeng, 18(1), pp.25~29 (2003)
39. Lee SY, "Reactive oxygen species induce epithelial‑mesenchymal transition, glycolytic switch, and mitochondrial repression through the Dlx‑2", Snail signaling pathways in MCF‑7 cells, 2019, pp.20(3), 2339~2346
40. Lin K, "The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB", Snail, PTEN Circuit, pp.Genes Cancer, 2010[DOI]
41. Xu W, "A new role for the PI3K", Akt signaling pathway in the epithelial-mesenchymal transition, 2015, pp.9(4), 317~324
42. Wu W, "Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β", Smad3 signaling-mediated renal fibrosis and inflammation, 2021, pp.16(1), 118~
43. Zhang L, "Signaling interplay between transforming growth factor-β receptor and PI3K", AKT pathways in cancer, 2013, pp.38(12), 612~620
44. Kaufhold S, "Central role of Snail1 in the regulation of EMT and resistance in cancer : a target for therapeutic intervention", J Exp Clin Cancer Res, 33(1), pp.62~ (2014)
45. Sharma SV, "Epidermal growth factor receptor mutations in lung cancer", Nat Rev Cancer, 7(3), pp.169~181 (2007)
46. Zhang X, "N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines", PLoS One, 8(3), pp.e57692~ (2013)
47. Weng CH, "Epithelial-mesenchymal transition(EMT)beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI", Oncogene, 38(4), pp.455~468 (2019)

관련 논문AI추천